{"id":"https://openalex.org/W4387729628","doi":"https://doi.org/10.1001/jamadermatol.2023.3830","title":"Janus Kinase Inhibitors and Adverse Events of Acne","display_name":"Janus Kinase Inhibitors and Adverse Events of Acne","publication_year":2023,"publication_date":"2023-10-18","ids":{"openalex":"https://openalex.org/W4387729628","doi":"https://doi.org/10.1001/jamadermatol.2023.3830","pmid":"https://pubmed.ncbi.nlm.nih.gov/37851459","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10585588"},"language":"en","primary_location":{"id":"doi:10.1001/jamadermatol.2023.3830","doi":"https://doi.org/10.1001/jamadermatol.2023.3830","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jamadermatol.2023.3830","pdf_url":null,"source":{"id":"https://openalex.org/S146641495","display_name":"JAMA Dermatology","issn_l":"2168-6068","issn":["2168-6068","2168-6084"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Dermatology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10585588","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Jeremy Martinez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeremy Martinez","raw_affiliation_strings":["Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts","Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774"]},{"raw_affiliation_string":"Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079701488","display_name":"Cyriac Manjaly","orcid":"https://orcid.org/0000-0001-7076-2463","observed_orcids":["https://orcid.org/0000-0001-7076-2463"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cyriac Manjaly","raw_affiliation_strings":["Vanderbilt University, Nashville, Tennessee"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University, Nashville, Tennessee","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067262418","display_name":"Priya Manjaly","orcid":"https://orcid.org/0000-0001-8162-6256","observed_orcids":["https://orcid.org/0000-0001-8162-6256"]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Priya Manjaly","raw_affiliation_strings":["Boston University School of Medicine, Boston, Massachusetts","Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston University School of Medicine, Boston, Massachusetts","institution_ids":["https://openalex.org/I111088046"]},{"raw_affiliation_string":"Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078189393","display_name":"Sophia Ly","orcid":"https://orcid.org/0000-0002-7508-6422","observed_orcids":["https://orcid.org/0000-0002-7508-6422","https://orcid.org/0000-0002-8498-1496"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sophia Ly","raw_affiliation_strings":["College of Medicine, University of Arkansas for Medical Sciences, Little Rock","Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Medicine, University of Arkansas for Medical Sciences, Little Rock","institution_ids":["https://openalex.org/I79620101"]},{"raw_affiliation_string":"Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011433279","display_name":"Guohai Zhou","orcid":"https://orcid.org/0000-0002-8826-403X","observed_orcids":["https://orcid.org/0000-0002-8826-403X"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guohai Zhou","raw_affiliation_strings":["Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037026685","display_name":"John S. Barbieri","orcid":"https://orcid.org/0000-0002-5467-4102","observed_orcids":["https://orcid.org/0000-0002-5467-4102"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Barbieri","raw_affiliation_strings":["Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083722360","display_name":"Arash Mostaghimi","orcid":"https://orcid.org/0000-0002-6084-5617","observed_orcids":["https://orcid.org/0000-0002-6084-5617"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Arash Mostaghimi","raw_affiliation_strings":["Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5083722360"],"corresponding_institution_ids":["https://openalex.org/I1283280774"],"apc_list":null,"apc_paid":null,"fwci":2.9747,"has_fulltext":false,"cited_by_count":69,"citation_normalized_percentile":{"value":0.93228346,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"159","issue":"12","first_page":"1339","last_page":"1339"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.022600000724196434,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.8610000014305115},{"id":"https://openalex.org/keywords/acne-vulgaris","display_name":"acne","score":0.7080000042915344},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7760000228881836},{"id":"https://openalex.org/keywords/abrocitinib","display_name":"abrocitinib","score":0.9200000166893005},{"id":"https://openalex.org/keywords/baricitinib","display_name":"baricitinib","score":1.0},{"id":"https://openalex.org/keywords/upadacitinib","display_name":"upadacitinib","score":1.0},{"id":"https://openalex.org/keywords/deucravacitinib","display_name":"deucravacitinib","score":0.984000027179718},{"id":"https://openalex.org/keywords/jak1-inhibitor","display_name":"JAK1 inhibitor","score":0.781000018119812},{"id":"https://openalex.org/keywords/jak2-inhibitors","display_name":"JAK2 inhibitors","score":0.8920000195503235},{"id":"https://openalex.org/keywords/tyk2-inhibitor","display_name":"TYK2 inhibitor","score":0.6349999904632568},{"id":"https://openalex.org/keywords/skin-diseases","display_name":"skin diseases","score":0.49900001287460327},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6019999980926514}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9418387413024902},{"id":"https://openalex.org/C2777673923","wikidata":"https://www.wikidata.org/wiki/Q79928","display_name":"Acne","level":2,"score":0.7356826663017273},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7328479290008545},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6274787187576294},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.6093350648880005},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5685833096504211},{"id":"https://openalex.org/C112392421","wikidata":"https://www.wikidata.org/wiki/Q903451","display_name":"Janus kinase","level":3,"score":0.560961127281189},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4770059883594513},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.47172465920448303},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.41867464780807495},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.2970978021621704},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.1228451132774353},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.07919946312904358},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000075242","descriptor_name":"Janus Kinase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000152","descriptor_name":"Acne Vulgaris","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D000152","descriptor_name":"Acne Vulgaris","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1001/jamadermatol.2023.3830","doi":"https://doi.org/10.1001/jamadermatol.2023.3830","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jamadermatol.2023.3830","pdf_url":null,"source":{"id":"https://openalex.org/S146641495","display_name":"JAMA Dermatology","issn_l":"2168-6068","issn":["2168-6068","2168-6084"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Dermatology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10585588","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10585588","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Dermatol","raw_type":"Text"},{"id":"pmid:37851459","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37851459","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA dermatology","raw_type":"Meta-Analysis"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:10585588","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10585588","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Dermatol","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W430898908","https://openalex.org/W1952507411","https://openalex.org/W2069236338","https://openalex.org/W2098923148","https://openalex.org/W2159659449","https://openalex.org/W2167305078","https://openalex.org/W2508306553","https://openalex.org/W2758867833","https://openalex.org/W2768516807","https://openalex.org/W2794348557","https://openalex.org/W2803975545","https://openalex.org/W2892136519","https://openalex.org/W2899259208","https://openalex.org/W2912001609","https://openalex.org/W2926411573","https://openalex.org/W2991540591","https://openalex.org/W3011005746","https://openalex.org/W3032018657","https://openalex.org/W3035077806","https://openalex.org/W3041952258","https://openalex.org/W3082277519","https://openalex.org/W3089470786","https://openalex.org/W3136297743","https://openalex.org/W3161578803","https://openalex.org/W3164705475","https://openalex.org/W3169855608","https://openalex.org/W3171539837","https://openalex.org/W3186417459","https://openalex.org/W3196175031","https://openalex.org/W3198816919","https://openalex.org/W4220744609","https://openalex.org/W4220917957","https://openalex.org/W4221127450","https://openalex.org/W4226328998","https://openalex.org/W4229366062","https://openalex.org/W4233484026","https://openalex.org/W4245244108","https://openalex.org/W4255139604","https://openalex.org/W4256050980","https://openalex.org/W4280531994","https://openalex.org/W4281674067","https://openalex.org/W4284989117","https://openalex.org/W4285984591","https://openalex.org/W4295807681","https://openalex.org/W4304128272","https://openalex.org/W4306173423","https://openalex.org/W4306839892","https://openalex.org/W4309388149","https://openalex.org/W4319842849"],"related_works":["https://openalex.org/W6902204866","https://openalex.org/W4386726289","https://openalex.org/W7167461929","https://openalex.org/W7133716047","https://openalex.org/W7196999378","https://openalex.org/W4390685992","https://openalex.org/W4389477435","https://openalex.org/W4411219835","https://openalex.org/W7125154979","https://openalex.org/W4385998486"],"abstract_inverted_index":{"Importance:":[0],"Janus":[1],"kinase":[2,258],"(JAK)":[3],"inhibitors":[4,35,57,97,223,242,251,260],"are":[5,303],"increasingly":[6],"used":[7],"across":[8,33,216],"a":[9],"range":[10],"of":[11,16,30,55,61,67,74,95,105,129,134,150,221,227,283,295,310],"dermatologic":[12,228],"conditions.":[13],"Adverse":[14],"events":[15,104],"acne":[17,62,135],"have":[18],"been":[19,38],"noted":[20],"in":[21,24,99,165],"some":[22],"studies":[23,153,217,302],"clinical":[25,52],"practice,":[26],"but":[27],"the":[28,59,132,166,219,225,308],"scope":[29],"this":[31,269,291,311],"outcome":[32,128],"JAK":[34,56,96,137,222,274],"has":[36],"not":[37],"established.":[39],"Objective:":[40],"To":[41],"systematically":[42],"analyze":[43],"all":[44,119],"published":[45,98],"phase":[46,89],"2":[47,90,259],"and":[48,77,91,109,115,124,160,206,249,256,266,272],"3":[49,92],"placebo-controlled":[50,93],"randomized":[51],"trials":[53],"(RCTs)":[54],"for":[58,185,224,240],"risk":[60],"as":[63,237,239],"an":[64,280],"adverse":[65,103,293],"effect":[66,294],"these":[68,296],"medications.":[69],"Data":[70,107],"Sources:":[71],"Comprehensive":[72],"search":[73],"Ovid":[75],"MEDLINE":[76],"PubMed":[78],"databases":[79],"through":[80],"January":[81],"31,":[82],"2023.":[83],"Study":[84],"Selection:":[85],"Inclusion":[86],"criteria":[87],"were":[88,163,214],"RCTs":[94],"English":[100],"with":[101,182,230,279],"reported":[102],"acne.":[106,284],"Extraction":[108],"Synthesis:":[110],"Two":[111],"reviewers":[112],"independently":[113],"reviewed":[114],"extracted":[116],"information":[117],"from":[118],"included":[120,164],"studies.":[121],"Main":[122],"Outcomes":[123],"Measures:":[125],"The":[126,169],"primary":[127],"interest":[130],"was":[131,142,174,277],"incidence":[133],"following":[136],"inhibitor":[138,275],"use.":[139],"A":[140,148],"meta-analysis":[141],"conducted":[143],"using":[144],"random-effects":[145],"models.":[146],"Results:":[147],"total":[149],"25":[151],"unique":[152,156],"(10":[154],"839":[155],"participants;":[157],"54%":[158],"male":[159],"46%":[161],"female)":[162],"final":[167],"analysis.":[168],"pooled":[170],"odds":[171,282],"ratio":[172],"(OR)":[173],"calculated":[175],"to":[176,305],"be":[177,287],"3.83":[178],"(95%":[179],"CI,":[180,189,194,199,204,210,235,245,254,263],"2.76-5.32)":[181],"increased":[183],"ORs":[184,213],"abrocitinib":[186],"(13.47":[187],"[95%":[188,193,198,203,209,234,244,253,262],"3.25-55.91]),":[190],"baricitinib":[191],"(4.96":[192],"2.52-9.78]),":[195],"upadacitinib":[196],"(4.79":[197],"3.61-6.37]),":[200],"deucravacitinib":[201],"(2.64":[202,261],"1.44-4.86]),":[205],"deuruxolitinib":[207],"(3.30":[208],"1.22-8.93]).":[211],"Estimated":[212],"higher":[215],"investigating":[218],"use":[220,276],"management":[226],"compared":[229],"nondermatologic":[231],"conditions":[232],"(4.67":[233],"3.10-7.05])":[236],"well":[238],"JAK1-specific":[241],"(4.69":[243],"3.56-6.18]),":[246],"combined":[247],"JAK1":[248],"JAK2":[250],"(3.43":[252],"2.14-5.49]),":[255],"tyrosine":[257],"1.44-4.86]).":[264],"Conclusions":[265],"Relevance:":[267],"In":[268],"systematic":[270],"review":[271],"meta-analysis,":[273],"associated":[278],"elevated":[281],"Patients":[285],"should":[286],"properly":[288],"counseled":[289],"on":[290],"potential":[292],"medications":[297],"before":[298],"treatment":[299],"initiation.":[300],"Future":[301],"needed":[304],"further":[306],"elucidate":[307],"pathophysiology":[309],"association.":[312]},"counts_by_year":[{"year":2026,"cited_by_count":25},{"year":2025,"cited_by_count":32},{"year":2024,"cited_by_count":12}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2023-10-19T00:00:00"}